News from the FDA/CDC

News from the FDA/CDC

FDA asks drug maker to shelve Opana ER

This marks the first time the agency has acted to remove an opioid pain medication because of the public health consequences of abuse.

News from the FDA/CDC

FDA approves ibrutinib for refractory MZL

The Food and Drug Administration has approved ibrutinib for the treatment of patients with relapsed or refractory marginal zone lymphoma, the drug...

Pages